Back
Zymeworks, Inc. Vs. NovaBay Pharmaceuticals, Inc. Industry Stock Comparison
Buy
67
ZYME
Zymeworks, Inc.
Last Price:
$26.71
Seasonality Move:
-5.1%
Buy
70
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$4.81
Seasonality Move:
10.47%
Buy
67
Zymeworks, Inc. (ZYME)
is a Buy
Is Zymeworks, Inc. a Buy, Sell or Hold?
-
The current Zymeworks, Inc. [ZYME] share price is $26.74. The Score for ZYME is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
ZYME is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $4.86. The Score for NBY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ZYME Stock Price Chart
What is Zymeworks, Inc.'s stock price today?
-
The Zymeworks, Inc. share price today is $26.74Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZYME is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals, Inc.'s stock price today?
-
The NovaBay Pharmaceuticals, Inc. share price today is $4.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZYME Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.46 | Buy |
| Relative Strength Index (14 RSI): | 60.69 | Buy |
| Chaikin Money Flow: | 270761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.35 - 26.99) | Buy |
| Bollinger Bands (100): | (14.54 - 23.72) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 72.71 | Buy |
| Chaikin Money Flow: | 315548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.98 - 4.12) | Buy |
| Bollinger Bands (100): | (0.62 - 2.84) | Buy |
ZYME Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.76 | Sell |
| 20-day SMA: | 26.25 | Buy |
| 50-day SMA: | 22.68 | Buy |
| 200-day SMA: | 15.74 | Buy |
| 8-day EMA: | 23.24 | Buy |
| 20-day EMA: | 14.77 | Buy |
| 50-day EMA: | 7.34 | Buy |
| 200-day EMA: | 2.06 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.53 | Buy |
| 20-day SMA: | 2.95 | Buy |
| 50-day SMA: | 1.84 | Buy |
| 200-day SMA: | 1.16 | Buy |
| 8-day EMA: | 4.41 | Buy |
| 20-day EMA: | 3.36 | Buy |
| 50-day EMA: | 2.2 | Buy |
| 200-day EMA: | 0.87 | Buy |
Zymeworks, Inc. Earnings Growth & ZYME Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $1.15 per share.
NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Zymeworks, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||